Cannabis Europa London, 2024, Europe’s foremost conference that connects influential leaders in science, policy and business, is now less than a week away.
We are proudly supported by the industry’s most influential and innovative businesses. Our sponsors are the backbone of our conference, playing an essential role in fostering an environment where ideas flourish and partnerships thrive.
Curaleaf International
This year’s headline sponsor, Curaleaf International, is one of the most prominent cannabis companies across the globe, with a presence in he UK, Germany, France, Italy, Switzerland, Spain, Portugal, Poland and the Czech Republic.
Curaleaf International brings its unparalleled expertise and commitment to advancing the medical cannabis industry in Europe. As a market leader on a rapid growth trajectory, Curaleaf International is driven by research and the highest degree of scientific rigour, thereby setting the standard for this industry.
During the conference, Curaleaf’s Executive Chairman Boris Jordan will take to the stage at 2pm on Tuesday 25th June to discuss Curaleaf’s international expansion.
Curaleaf International’s Managing Director will also take to the stage on Tuesday to discuss the future of the UK’s medical market, while the head of Curaleaf International, Juan Martinez, will also be speaking on the future of the European market and the global supply chain.
Brains Bioceutical
Brains Bioceutical is a global leader in the production of pharmaceutical-grade cannabinoid APIs. With extensive licenses and certifications, including GMP and GDP certifications, Brains Bioceutical ensures the highest quality and consistency in their 100% natural hemp-derived products.
The company has a strong management team with expertise in finance, M&A, and the cannabis sector. Their exclusive partnerships, like those with DSM and Vitabiotics, enhance their market reach and innovation in CBD-based pharmaceuticals. Brains Bioceutical is pioneering advancements in cannabinoid health and wellness solutions worldwide.
Brains Biocuetical will be giving a keynote speech at 11am on the main stage on the second day of the conference.
Cannavigia
Cannavigia, a pioneering Swiss tech start-up, stands at the forefront of transforming process and compliance management in the cannabis cultivation and manufacturing industry. Their solutions, distinguished by intuitive design and advanced technology, are anchored in a commitment to client-centric excellence.
Cannavigia seamlessly integrates cannabis dispensing monitoring into its suite of services, enhancing comprehensive compliance management. Their involvement in Swiss pilot projects, supported by a long-term contract with the Federal Office of Public Health of Switzerland, underscores their leadership and dedication in shaping responsible cannabis use and distribution.
Luc Richner, Cannavigia and Vigia AG’s CEO, will be speaking on Wednesday on the importance of data and technology in building a successful cannabis company.
4C Labs
4C Labs is an importer and distributor of cannabis prescription medicines. Our focus is on finding, approving and bringing what we feel are the best value products in the market to the UK. We take a patients first approach. We believe that the UK market is just being born, and are proud to play our part in it.
On that thread, 4C Lab’s CEO Greg Dobbin will be speaking on the first day of the conference about the future of the UK’s medical cannabis market, before its CRO James Smith discusses the discrepancies between the UK’s patient numbers compared to its European counterparts.
Jorja Healthcare Group
Jorja Healthcare is a UK based clinical services provider specialising in innovative treatment solutions across a range of disciplines.
Jorja Healthcare offers advanced diagnostic and treatment solutions in MSK, neurology, mental health and medical cannabis treatment, with patients benefiting from an integrated service that includes MRI scans, lab services, orthopedic surgeries, outpatient treatment and prescription fulfilment.
Grow Group
Grow Group PLC is a European medical cannabis company focused on improving patient access to cannabis-based medicines. They provide a range of high-quality products through their partnerships and collaborations with leading healthcare providers and pharmaceutical companies. Grow Group operates with a mission to standardise medical cannabis treatment and expand its accessibility across Europe, ensuring patients receive safe and effective therapeutic options.
Grow Pharma’s CEO, Pierre Van Weperen, will be discussing the growth of the UK’s medical cannabis market on Tuesday at 12.20pm.
Astrasana Holding AG
Astrasana Holding is an established Swiss pharmaceutical and cannabis company. With its headquarters in Switzerland and three additional companies in the UK, Czech Republic and Japan, Astrasana employs a total of around 30 people and distributes its products in over 18 countries worldwide.
On Wednesday, Astrasana Czech’s Tomas Ryska will be discussing the future of the Czech Republic’s ambitious cannabis legalisation project.
Paralab Green
Paralab Green provides a comprehensive lineup of equipment tailored for the cannabis industry, covering production, postharvest, extraction, purification, packaging, and analytical instrumentation for process control and quality assurance.
Ziel
Ziel is the industry leader providing next-generation customised, microbial control solutions for the agriculture and cannabis industries. The markets in which the company currently operates include tree nuts, seeds, and select fruit, as well as cannabis and hemp. Ziel’s products harness radio frequency and microwave technologies to build customised solutions that help customers consistently meet regulatory requirements, preserve product integrity, improve operational processes, and maximise profits. Ziel has a worldwide clientele who commercially process food and cannabis products with installations in the United States, Canada, Australia, Chile, Mexico, Germany, and Portugal. Ziel’s corporate headquarters are located in San Francisco.
On the second day of the conference, Ziel’s President and CEO, Arthur de Cordova, will be discussing when the mainstream pharmaceutical industry will embrace cannabinoids.
Tikun Olam Europe
Tikun Olam Greece SA was founded in 2018 in Greece, utilizing country’s potential to become an international center for the production and trading of innovative finished medical cannabis products under prescription, based on the Tikun Olam Israel know-how. Tikun Olam Israel is a pioneering company in research, development, and production of medical cannabis products worldwide, with more than 17 years of clinical and laboratory studies, with an extensive patient database.
Tikun Olam Greece SA with a total investment of over €47m, in state-of-the-art facilities of 56,000m2, is transforming the healthcare landscape with its finished medical cannabis products under prescription. Its activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis. Tikun Olam Greece SA develops finished medical cannabis products under prescription that are produced in an EU-GMP environment under strict control standards and procedures which ensure high quality and safety.
Tikun Olam Greece SA finished medical cannabis products under prescription offer support for serious conditions, such as Cancer, Multiple Sclerosis, HIV, Hepatitis C, Chronic Neuropathic Pain.
Nikos Beis, CEO and Vice President of Tikun Olam Europe, will be discussing the relatively new medical cannabis market of Greece in one of the conferences first sessions on Tuesday.
Linnea Cannabinoids
With over 40 years experience Linnea’s extensive expertise sets the company apart and guarantees quality and innovation.
Since 1982 Linnea has been committed to high quality botanical API manufacturing in our GMP certified facility in Ticino Switzerland.
With a focus on sustainability and the environment, Linnea is a leading pharmaceutical manufacturer producing both botanical extracts & isolates and semi-synthetic APIs derived from botanicals
Tyson 2.0
A premier hemp company formed with legendary boxer, entrepreneur and icon Mike Tyson. Our mission is to produce innovative, high-quality hemp products known for purity, precision, and wide accessibility. Providing consumers an outstanding selection of products, Tyson 2.0 Global is an extraordinary balance of premium and affordable CBD concentrates and consumables available nationwide.
NextGen Consulting LLC
We are a collective of top-tier business and category consultants, each bringing their unique expertise to your project. Each holds an exceptional track record and expertise in a specific area of business and when combined in collaboration, drives an evolution forward to re-think and revitalise business consultancy and how we engage our clients and projects we are honoured to be a part of. Becoming a client of our collective group means gaining access to a diverse pool of expertise with refined strategies and mentalities of innovation & excellence.
We Are Business Development & Strategy Experts and are committed to revolutionising the way businesses operate within emerging markets & industries. Our mission is to empower organisations, from startups to established enterprises, to achieve unparalleled success through tailored strategies that maximize strategy, efficiency, profitability, and actual business development. We recognise the importance of a customised approach to develop and implement the necessary energy and activities to accomplish your goals and achieve your vision.
NextGen’s Founder and CEO Anthony Adkins will be hosting a Business Development and Strategy Workshop in the Greenhouse on day one of the conference.
Cannprisma
Cannprisma-pharma is a 100% Portuguese company founded in 2018, which is dedicated to growing, processing, and transforming the cannabis plant for medical purposes. Cannprisma develops its activity along the entire value chain, with a seed-to-sale structure that provides solutions for growers, pharmaceutical wholesalers, pharmaceutical manufacturers and for researchers.
CanXchange
Canxchange is a B2B market infrastructure that facilitates industrial hemp, CBD and medical cannabis transactions. We are the industry first, marketplace and electronic platform that connects businesses to help them transact in a secure, fast and transparent environment. With Canxchange, businesses can access a network of the leading vetted suppliers, offering GACP and EU GMP products. Compliance and risk assessments are the cornerstones of our end-to-end solution.
Canexis Pharma AG
Canexis Pharma AG will be exhibiting at Cannabis Europa 2024 in London! This is one of the leading medical cannabis trade fairs in Europe, known for its networking opportunities, interesting panels and the chance to meet the market leaders. Make an appointment with us on June 25th and 26th, 2024 to see what a collaboration with Canexis can look like and to learn more about what we have to offer. You can find us on the exhibition floor at stand G34-35.
Canexis Pharma AG has all the regulatory approvals and technical capabilities to meet the growing demand for medical cannabis of the highest quality and for all individual requirements.
Currently, custom-made prescription medicines dominate the medical cannabis market. We plan to enrich this market with a range of finished medicines based on pure active ingredients extracted directly from the plant. Canexis’ production facility can process up to 1 kg of cannabis per day, resulting in 000 kg of pure active ingredients per day. This means Canexis can meet the daily needs of one to four million patients.
Phcann International
Phcann International is a multinational pharmaceutical company, operating in accordance with EU GMP standards, with Headquarters in Amsterdam, Netherlands.
Our corporate social responsibility is to provide patients in need of products containing high-quality cannabinoids of natural origin and to disseminate knowledge about the therapeutic use of cannabinoids. We work closely with partners, doctors, and patients to fully understand patient needs.
Phcann’s mission is to make available a wide range of medical cannabis preparations for patients, who can benefit clinically, at the right time, and at an affordable cost.
Retsch
Retsch is the leading solution provider for neutral-to-analysis sample preparation and characterisation of solids. Based on more than 100 years of experience Retsch develops innovative size reduction and sieving equipment which is characterised by excellent performance, operating convenience, safety and a long lifetime.
Retsch is putting to use its full product portfolio to help process and prepare samples. Whether the samples are cannabis flower, gummy bears, brownies, or candies, Retsch can provide assistance in selecting the ideal instrument to meet the application requirements.
Viridian Capital Advisors
Launched in 2014, Viridian Capital Advisors was one of the first and now leading, corporate finance, advisory and M&A practices in the legal Cannabis/CBD industries, and now in the Psychedelics sector. We represent companies, investors, lenders, buyers and sellers. Our advisory practice is meant to help “institutionalize” our clients before they go to market for capital or M&A – by helping to build a professional Board of Directors, sophisticated financial models and valuation analyses, exit strategies and strategic advisory services. Our investment banking practice raises capital and executes M&A transactions through our New York City based broker-dealer, Bradley Woods & Co. Ltd.
Viridian is widely recognized as the industry leader in research and capital markets data/market intelligence through the Viridian Deal Tracker. Launched in January 2015, the Viridian Deal Tracker is a proprietary data service that monitors and analyzes investment, M&A activity and capital markets trends in the Cannabis, Hemp and Psychedelics industries. We’ve tracked and analyzed more than 6,500 transactions totaling more than $70 billion in transaction value. We know where equity investors invest, where lenders lend and where acquirers acquire. The Deal Tracker is received and read every day by thousands of leading industry players on a global basis, becoming a trusted and valuable source for companies, investors, lenders and sellers/acquirers to make informed capital allocation decisions.
Terpenia
Terpenia specialises in cultivating and producing standardised medical cannabis extracts and flowers for the Greek and other European markets.
Our primary emphasis is on the development of finished pharmaceutical formulations, focusing on generating intellectual property.
Terpenia pioneers intellectual property (IP) in innovative cannabis medications through in-house research, formulation, trials, and pharmaceutical approval.
We meticulously manufacture organic cannabis extracts and flowers meeting EU standards with a global distribution network. We deliver natural, effective cannabinoid-based medications, revolutionising patient care through personalised approaches.
Pure Support
Pure Support is a pioneering leader in the Belgian cannabis market. Pure Support holds a distinguished position as a trailblazer in the Belgian cannabis industry. In 2019, the company made history by introducing cannabis flowers (with a legal THC content below 0.2%) as a tobacco substitute, becoming the first to do so in the nation.
Pure Support has solidified its leadership role by establishing its own bonded customs warehouse. This strategic move has propelled them to become the leading cannabis company in Belgium. Their extensive brand distribution network encompasses over 2,500 points of sale, further amplified by their presence in 7 strategically located concept retail stores.
Pure Support remains at the forefront of the evolving Belgian cannabis market. Their early market entry has secured their position as a key player across various sectors, including production, distribution, wholesale, and retail. As the market continues its upward trajectory, Pure Support expresses an unwavering commitment to growth and the development of novel, wellness-oriented cannabis products.
True Terpenes
As a next-generation flavor house with an innovative terpene solutions platform, we create incredible sensory experiences under the industry’s highest safety standards. We are creators, scientists, and outside-the-box thinkers. We champion the terpene kingdom with science-based research and leverage sensory analysis to create flavors and aromas that are true to experience.
Clever Leaves
Clever Leaves is a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids. Its operations in Colombia produce cannabinoid Active Pharmaceutical Ingredients (API) and finished products in flower and extract form to a growing base of B2B customers around the globe. Clever Leaves aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods, with the world’s most stringent pharmaceutical quality certifications.
We aim to be one of the industry’s leading global cannabis companies recognised for our principles, people, and performance while fostering a healthier global community. We have established a significant infrastructure and positioned ourselves to achieve global reach between our cultivation and extraction operations in Colombia and our global distribution.
Clever Leaves has received multiple international certifications that have enabled it to increase its export and sales capacity from its Colombian operations, including European Union Good Manufacturing Practices (EU GMP) Certification, a Good Manufacturing Practices (GMP) Certification by Colombia National Food and Drug Surveillance Institute – Invima, and Good Agricultural and Collecting Practices (GACP) Certification.
Blaze
Blaze powers the cannabis industry with intuitive technology solutions. Founded in 2015 by technology and cannabis entrepreneurs, the Blaze software suite provides point-of-sale, inventory management, e-commerce, payment processing, delivery, and analytics tools to cannabis businesses across North America. Blaze recently ranked 916 in the 2023 Inc. 5000 Fastest Growing Private Companies and was awarded KIND Magazine’s Best Retail POS Provider in Canada.
Flow Gardens
Flow Gardens believes in cultivating health and happiness through premium quality cannabis. We are changing the perception of the plant by educating our customers on the wellness benefits across the entire spectrum of cannabinoids. Our indoor R&D cultivation facility in East Tennessee, led by Erich Maelzer with over 25 years of experience, grows superior strains that provide rich terpenes and cannabinoids for an unmatched entourage effect.
Gowling WLG
Gowling WLG is a sector-focused international law firm with in-depth expertise and experience in key global sectors, including life sciences, tech, transport and infrastructure, energy, advanced manufacturing, government, and real estate. We believe that legal matters are people matters, and it takes closer relationships between people and teams to get to the best results, in the right way. It used to be that good lawyering was mostly about knowing the law and delivering sound opinions. Today, businesses need more and demand more. We anticipate what lies ahead and strive to create a positive experience for our clients, teams, and communities, aligning with shared values and responsible business practices.
